Douglas Johnson, MD
Dermatology · Honolulu, HINPI 1700869427
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $427,186 of the $568,479 with a category attached, or 75.1%. It is spread thinly across 28 manufacturers, the largest accounting for just 15.3%. Reporting peaked in 2024 at $158,532 and has fallen 60.5% since, to $62,605 in 2025. Among dermatology clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,379 payments — averaging $412.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$87K
- Lilly USA, LLC$80K
- UCB, Inc.$74K
- Regeneron Healthcare Solutions, Inc.$66K
- Novartis$47K
- Pfizer$43K
- plus $172K from 22 others
Across 2 payments — averaging $67,864 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$136K
What the payments were for
- Consulting fees$46,3288%
- Speaking & faculty fees$427,18675%
- Grants$8,0001%
- Travel & lodging$50,4819%
- Food & beverage$36,1486%
- Education$3360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 153 | $86,827 |
| Lilly USA, LLC | 136 | $80,367 |
| UCB, Inc. | 108 | $73,885 |
| Regeneron Healthcare Solutions, Inc. | 126 | $65,885 |
| Novartis | 151 | $46,850 |
| Pfizer | 64 | $43,097 |
| Amgen | 163 | $41,317 |
| Incyte Corporation | 48 | $22,895 |
| Sun Pharmaceutical Industries Inc. | 64 | $20,273 |
| Bristol Myers Squibb | 22 | $16,957 |
| Galderma Laboratories, L.p. | 38 | $16,323 |
| Sanofi | 59 | $16,150 |
| E.r. Squibb & Sons, L.L.C. | 60 | $9,886 |
| LEO Pharma Inc. | 74 | $8,891 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 30 | $7,767 |
| Dermira, Inc. | 10 | $5,879 |
| Dermavant Sciences, Inc. | 4 | $2,813 |
| Arcutis Biotherapeutics, Inc. | 30 | $1,049 |
| Johnson & Johnson | 18 | $468 |
| Genentech USA, Inc. | 10 | $202 |
| Regeneron | 1 | $161 |
| Sanofi US Services Inc. | 1 | $135 |
| Sanofi-aventis U.S. LLC | 2 | $117 |
| Almirall LLC | 1 | $97 |
| Smith+Nephew | 3 | $69 |
| Blueprint Medicines Corporation | 1 | $63 |
| Organon | 1 | $31 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$568,479 in reported general payments places this provider in the 95th percentile of 67 dermatology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bimzelx AutoinjectorBimekizumab-Bkzx | 12 | $166,293 |
| Dupixent SyringeDupilumab | 41 | $164,510 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $94,255 |
| Tacrolimus | 29 | $5,596 |
| Betamethasone Dipropionate | 100 | $4,993 |
| Fluocinonide | 85 | $4,024 |
| Clobetasol Propionate | 33 | $2,142 |
| Alclometasone Dipropionate | 45 | $2,008 |
| Ketoconazole | 100 | $1,780 |
| MethotrexateMethotrexate Sodium | 53 | $1,632 |
| Triamcinolone Acetonide | 136 | $1,475 |
| Hydrocortisone | 104 | $1,282 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 26 | $1,229 |
| Halobetasol Propionate | 21 | $1,079 |
| Fluorouracil | 15 | $1,069 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Honolulu
- Sarah HowellHonolulu$653K
- Ryan SatoHonolulu$226K
- Greg SakamotoHonolulu$20K
- Kory KitagawaHonolulu$18K
- Kevin DawsonHonolulu$16K
- Dylan LeeHonolulu$15K
- Sarah GrekinHonolulu$13K
- Gregory HerbichHonolulu$12K
- Stella MatsudaHonolulu$9K
- Aaron FongHonolulu$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.